October 21, 2002
Volume 80, Number 42
CENEAR 80 42 pp. 20-21
ISSN 0009-2347

[Back To Story]

DRUG AND BIOTECH STOCKS
Stock prices are down, but they outperform broader markets in the quarter


THIRD-QUARTER STOCK PRICEa CHANGE FROM SECOND-QUARTER CHANGE FROM 2001 PRICE/
EARNINGS

HIGH LOW CLOSE CLOSE CLOSE RATIOb
MAJOR PHARMACEUTICAL COMPANIES
Abbott Laboratories $43.80 $31.00 $40.40 7.3% –27.5% 20
Baxter International 43.41 30.55 30.55 –31.3 –43.0 18
Bristol-Myers Squibb 26.17 20.55 23.80 –7.4 –53.3 13
Eli Lilly 62.15 48.15 55.34 –1.9 –29.5 23
Johnson & Johnson 56.20 41.85 54.08 3.5 –8.5 26
Merck 53.80 39.05 45.71 –9.7 –22.3 15
Pfizer 34.92 25.92 29.02 –17.1 –27.2 21
Pharmacia 46.25 31.32 38.88 3.8 –8.8 26
Schering-Plough 25.50 20.75 21.32 –13.3 –40.5 13
Wyeth 49.90 29.75 31.80 –37.9 –48.2 13
C&EN pharmaceutical indexc (1992 = 100) 394 304 342 –10.7% –30.9% --
Dow Jones industrial average 9380 7592 7592 –17.9% –24.2% --
BIOPHARMACEUTICAL AND DRUG DISCOVERY COMPANIES
Amgen $48.54 $31.07 $41.70 –0.4% –26.1% 32
Biogen 38.95 29.08 29.27 –29.4 –49.0 17
Celera Genomics 11.38 7.41 7.95 –33.8 –70.2 def
Cephalon 48.50 36.81 40.82 –9.7 –46.0 def
Chiron 41.98 27.41 34.94 –1.2 –20.3 33
Cytogen 1.00 0.40 0.40 –62.7 –86.7 def
Genentech 36.90 25.50 32.63 –2.6 –39.9 38
Genzyme 25.34 16.88 20.61 7.1 –65.6 20
Gilead Sciences 37.04 26.55 33.53 2.0 –49.0 def
Icos 28.96 13.84 20.97 23.8 –63.5 def
MedImmune 29.79 20.87 20.87 –20.9 –55.0 37
Millennium Pharmaceuticals 14.66 8.75 9.32 –23.3 –62.0 def
Protein Design Labs 13.59 8.30 8.30 –23.6 –74.7 def
Vertex Pharmaceuticals 23.68 12.95 18.49 13.6 –24.8 def
Xoma 6.58 3.38 6.27 57.1 –36.4 def
C&EN biopharmaceutical indexd (1992 = 100) 324 229 261 –7.4% –44.7% --
NASDAQe index 1448 1172 1172 –20.0% –39.9% --

a Adjusted for stock splits. b As of Sept. 30. Excludes extraordinary and nonrecurring items. c Based on average stock value for the above-named 10 companies. d Based on average stock value for the above-named 15 companies. e National Association of Securities Dealers Automated Quotations. def = deficit in previous four quarters.

[Back To Story]


Top


Chemical & Engineering News
Copyright © 2002 American Chemical Society